Harold Mars

403 total citations
20 papers, 300 citations indexed

About

Harold Mars is a scholar working on Neurology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Harold Mars has authored 20 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 5 papers in Clinical Biochemistry and 4 papers in Molecular Biology. Recurrent topics in Harold Mars's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Metabolism and Genetic Disorders (5 papers) and Neurological disorders and treatments (5 papers). Harold Mars is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Metabolism and Genetic Disorders (5 papers) and Neurological disorders and treatments (5 papers). Harold Mars collaborates with scholars based in United States and Canada. Harold Mars's co-authors include André Barbeau, Abel L. Robertson, Guy H. Williams, Lena A. Lewis, A. Barbeau, Antanas Butkus, Saul Genuth, Marshall H. Klaus, Avroy A. Fanaroff and John Kattwinkel and has published in prestigious journals such as JAMA, Neurology and Cancer.

In The Last Decade

Harold Mars

18 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harold Mars United States 9 144 63 57 38 33 20 300
Yahr United States 12 241 1.7× 114 1.8× 21 0.4× 31 0.8× 42 1.3× 32 419
L Kirstein Sweden 9 47 0.3× 66 1.0× 36 0.6× 29 0.8× 66 2.0× 17 313
Tyce Gm United States 11 388 2.7× 213 3.4× 17 0.3× 102 2.7× 54 1.6× 17 549
P. L. Del Bianco Italy 10 41 0.3× 80 1.3× 19 0.3× 113 3.0× 63 1.9× 34 320
GEORGE P. GEWIRTZ United States 10 67 0.5× 147 2.3× 203 3.6× 124 3.3× 159 4.8× 14 613
E R Love Poland 11 68 0.5× 110 1.7× 87 1.5× 267 7.0× 118 3.6× 14 515
K. Laakso United States 11 81 0.6× 145 2.3× 21 0.4× 90 2.4× 94 2.8× 16 418
L. Palj�rvi Finland 8 75 0.5× 137 2.2× 16 0.3× 74 1.9× 94 2.8× 8 355
K. Sullivan United States 9 85 0.6× 86 1.4× 93 1.6× 182 4.8× 84 2.5× 13 438
Roland Galmbacher Germany 7 50 0.3× 80 1.3× 18 0.3× 42 1.1× 63 1.9× 10 335

Countries citing papers authored by Harold Mars

Since Specialization
Citations

This map shows the geographic impact of Harold Mars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold Mars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold Mars more than expected).

Fields of papers citing papers by Harold Mars

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold Mars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold Mars. The network helps show where Harold Mars may publish in the future.

Co-authorship network of co-authors of Harold Mars

This figure shows the co-authorship network connecting the top 25 collaborators of Harold Mars. A scholar is included among the top collaborators of Harold Mars based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold Mars. Harold Mars is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braunstein, Alfredo, et al.. (1976). Progesterone antagonism of aggression-promoting olfactory signals: A time-dependent phenomenon☆. Physiology & Behavior. 17(2). 319–323. 5 indexed citations
2.
Kattwinkel, John, Harold Mars, Avroy A. Fanaroff, & Marshall H. Klaus. (1976). Urinary biogenic amines in idiopathic apnea of prematurity. The Journal of Pediatrics. 88(6). 1003–1006. 18 indexed citations
3.
Mars, Harold. (1975). Effect of chronic levodopa treatment on pyridoxine metabolism. Neurology. 25(3). 263–263. 8 indexed citations
4.
Kattwinkel, John, Howard S. Nearman, Harold Mars, et al.. (1974). APNEA OF PREMATURITY: EFFECTS OF CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP), CUTANEOUS STIMULATION, AND LEVELS OF URINARY BIOGENIC AMINES. Pediatric Research. 8(4). 468–468. 1 indexed citations
5.
Mars, Harold. (1974). Levodopa, Carbidopa, and Pyridoxine in Parkinson Disease. Archives of Neurology. 30(6). 444–444. 15 indexed citations
6.
Mars, Harold. (1973). Metabolic interactions of pyridoxine, levodopa, and carbidopa in Parkinson's disease.. PubMed. 98. 241–5. 4 indexed citations
7.
Mars, Harold & Saul Genuth. (1973). Potentiation of levodopa stimulation of human growth hormone by systemic decarboxylase inhibition. Clinical Pharmacology & Therapeutics. 14(3). 390–395. 17 indexed citations
8.
Mars, Harold. (1973). Modification of Levodopa Effect by Systemic Decarboxylase Inhibition. Archives of Neurology. 28(2). 91–91. 34 indexed citations
9.
Schwartz, Arthur, et al.. (1972). The effects of levodopa therapy in patients with Parkinson's disease. I. Clinical response.. PubMed. 107(10). 973–6. 3 indexed citations
10.
Barbeau, André, et al.. (1972). Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease.. PubMed. 106(11). 1169–74. 18 indexed citations
11.
Barbeau, A., et al.. (1972). [Treatment of Parkinson's disease with L-dopa alone or combined with Ro 4-4602].. PubMed. 31. Suppl:169–74. 3 indexed citations
12.
Mars, Harold. (1972). Levodopa and Pyridoxine. JAMA. 219(13). 1764–1764.
13.
Mars, Harold. (1972). Levadopa and pyridoxine. JAMA. 219(13). 1764b–1764. 4 indexed citations
14.
Mars, Harold, et al.. (1972). L-Dopa in Parkinson's Disease: Results of a Co-Operative Study in the Montreal Area. Canadian Psychiatric Association Journal. 17(2). 123–132. 1 indexed citations
15.
Barbeau, A., et al.. (1971). Adverse clinical side effects of levodopa therapy.. PubMed. 8. 203–37. 41 indexed citations
16.
Barbeau, André, et al.. (1971). Treatment of Parkinson's disease with levodopa and Ro 4‐4602. Clinical Pharmacology & Therapeutics. 12(2part2). 353–359. 40 indexed citations
17.
Barbeau, André, et al.. (1971). Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.. PubMed. 105(1). 42–6 passim. 14 indexed citations
18.
Mars, Harold, Lena A. Lewis, Abel L. Robertson, Antanas Butkus, & Guy H. Williams. (1969). Familial hypo-β-lipoproteinemia. The American Journal of Medicine. 46(6). 886–900. 69 indexed citations
19.
Mars, Harold, O. P. Schumacher, & Lawrence J. McCormack. (1967). Intra-abdominal extrapancreatic neoplasm (leiomyosarcoma) associated with severe recurrent hypoglycemia.Report of a case. Cancer. 20(7). 1155–1160. 2 indexed citations
20.
Pengo, Vittorio, Harold Mars, & Michael Johnston. (1959). EFFECT OF X-IRRADIATION ON NORMAL, HYPOTHYROID, AND HYPERTHYROID RABBITS. Canadian Journal of Biochemistry and Physiology. 37(11). 1271–1275. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026